Block · one region of the page, as the scanner read it. It may hold a whole story, part of one, several, or an advertisement; stitching blocks into articles is the next step. Text is supplied OCR.
Page 7 · column 2 of 6 · from the scan, no model involved
It also allows for the states to enter into rebate agreements with drug manufacturers on behalf of non-Medicaid residents.
The Senate passed an identical bill in July 2002, by a 78 to 21 margin.
It enjoyed broad bipartisan support. Both Senator Warner and Senator Allen voted for it. This bill was sent to the House where it has languished in committee. Mr. Jones’ opponent, the incumbent Eric Cantor, has refused to add his name to a discharge petition which would bring the bill out of committee so that it could be voted on by the full House (where it likely would pass.)
During a radio debate with Ben Jones, Mr. Cantor said his first reason for not allowing a vote was that the pharmaceutical companies need the money for research. The truth is that these companies make more profit than any other industry in the United States. They spend twice as much money on advertising as they do on research. (It also happens that much research is done with our taxpayer dollars through the
94.1%